Search results for KIR2DL2 antibody

KIR2DL2 antibody, Genetex, GTX55865

Anti-KIR2DL1 + KIR2DL2 antibody [EPR22492-2], Abcam, AB224696

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-KIR2DL1 + KIR2DL2 antibody [EPR22492-79], Abcam, AB252937

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-KIR2DL1 + KIR2DL2 antibody [EPR22492-92], Abcam, AB252936

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-KIR2DL3 + KIR2DL1 + KIR2DL2 antibody [EPR22541-47], Abcam, AB224697

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Killer Cell Immunoglobulin Like Receptor 2DL2 (KIR2DL2) Antibody, Abbexa, abx270171

Killer Cell Immunoglobulin Like Receptor 2DL2 (KIR2DL2) Antibody is a Rabbit Polyclonal Antibody against Killer Cell Immunoglobulin Like Receptor 2DL2 (KIR2DL2) for use in flow cytometry.

Killer Cell Immunoglobulin Like Receptor 2DL2 (KIR2DL2) Antibody, Abbexa, abx104479

Polyclonal Antibody to Killer Cell Immunoglobulin Like Receptor 2DL2 (KIR2DL2).

Killer cell immunoglobulin-like receptor 2DL2 (KIR2DL2) Antibody, Abbexa, abx343673

Killer cell immunoglobulin-like receptor 2DL2 (KIR2DL2) Antibody is a Rabbit Polyclonal antibody for the detection of Human KIR2DL2.

Killer Cell Immunoglobulin Like Receptor 2DL2 (KIR2DL2) Antibody, Abbexa, abx032608

Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several 'framework' genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response.

Killer cell immunoglobulin-like receptor 2DL2 (KIR2DL2) Antibody (FITC), Abbexa, abx343675

Killer cell immunoglobulin-like receptor 2DL2 (KIR2DL2) Antibody (FITC) is a Rabbit Polyclonal antibody conjugated to FITC for the detection of Human KIR2DL2.